Clinical Trial Update: KSD-101 Therapy for Standard Treatment Failed EBV-associated NPC: an Exploratory Clinical Trial [EARLY_Phase 1]

View source ↗

Summary

An early-phase exploratory clinical trial evaluating KSD-101 therapy for EBV-associated nasopharyngeal carcinoma after standard treatment failure. The study is …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Nasopharyngeal Carcinoma

Drugs mentioned

• KSD-101

Snippet

Sponsor: Sun Yat-sen University | Conditions: Nasopharyngeal Carcinoma | EARLY_Phase 1 | Status: NOT_YET_RECRUITING